The trademark application CARISMA THERAPEUTICS was filed by Carisma Therapeutics Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on February 15, 2021, and it was registered by office on May 25, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Biological preparations, namely, preparations for use in the treatment of cancer and tumors
Biologic preparations for medical and therapeutic purposes for immunotherapy
Biological preparations for immunotherapy, including, macrophage platforms and T Cell therapy
Cells for medical or clinical use
Diagnostic kits consisting primarily of cells for medical or clinical use.